Bone Marrow Suppression caused by Chemotherapy

Drug	Drug Name	Drug Description
DB15442	Trilaciclib	A CDK4 and CDK6 inhibitor to reduce the risk of chemotherapy induced myelosuppression.

Drug	Drug Name	Target	Type
DB15442	Trilaciclib	Solute carrier family 22 member 2	transporter
DB15442	Trilaciclib	Multidrug and toxin extrusion protein 1	transporter
DB15442	Trilaciclib	Multidrug and toxin extrusion protein 2	transporter
DB15442	Trilaciclib	Cytochrome P450 1A2	enzyme
DB15442	Trilaciclib	ATP-binding cassette sub-family G member 2	transporter
DB15442	Trilaciclib	P-glycoprotein 1	transporter
DB15442	Trilaciclib	Cyclin-dependent kinase 4	target
DB15442	Trilaciclib	Cyclin-dependent kinase 6	target
DB15442	Trilaciclib	Cyclin-dependent kinase 9	target
DB15442	Trilaciclib	Cyclin-dependent kinase 2	target
DB15442	Trilaciclib	Cyclin-dependent kinase 5	target
DB15442	Trilaciclib	Cyclin-dependent kinase 7	target

Drug	Drug Name	Phase	Status	Count